Author

B. Schwartz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. R. Campos· 1 shared D. Sharipova· 1 shared J. M. Farma· 1 shared K. Devarajan· 1 shared L. Rink· 1 shared M. G. Belinsky· 1 shared M. Kozinova· 1 shared M. von Mehren· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. R. Campos

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor

M. Kozinova, S. Joshi, S. Ye, M. G. Belinsky, D. Sharipova, J. M. Farma, S. Reddy, S. Litwin, K. Devarajan, A. R. Campos, Y. Yu, B. Schwartz, M. von Mehren, L. Rink

This study shows that combining AKT and KIT inhibitors restores PDCD4 expression in GIST cells, leading to cell death, but the combination is less effective in IM-resistant models.

bioRxiv · Apr 13, 2021Cancer Biology